Can an amino acid supplement calm childhood eczema?
NCT ID NCT07670676
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a supplement containing L-histidine, along with a topical oil or lotion and unscented soap, could improve mild-to-moderate eczema in children. Forty children ages 1 to 12 were split into two groups: one received a powder supplement and the other a gummy supplement, both with the same amount of L-histidine. Researchers measured changes in eczema severity using standard scoring tools. The goal was to see if this combination could ease symptoms like itching, redness, and dryness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
L-histidine (amino acid) in powder or gummy supplements, plus topical oil or lotion and unscented soap
What this could lead to
If it works, this could point toward a simple, non-drug way to ease eczema symptoms in children.
What could go wrong
This is a small, completed study with only 40 children and no control group. Results may not apply to all kids, and supplements are not a substitute for medical treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (ECZEMA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Eurofins Dermscan Poland
Gdansk, Poland